Interní Med. 2006; 8(6): 270-273

Instruction for prevention of bacterial endocarditis

doc. MUDr. Petr Heinc Ph.D
I. interní klinika FN a LF UP Olomouc

Bacterial endocarditis unexpectedly develops in a case of bacteremia resulting from mucosal or skin surface damage but mostly it occurs due to injury during planned medical instrumentation. Year incidence of bacterial endocarditis is only 2–5/100 000 inhabitants but it’s mortality is about 10–30%. Risk of bacterial endocarditis increases with severity of the underlying heart disease and therefore the prophylaxis of bacterial endocarditis seems to be unavoidable. Patients with heart diseases are divided into groups associated with high, mild and negligible risk of bacterial endocarditis, with a special regard to mitral valve prolapse syndrome. Dental, respiratory, gastrointestinal, genitourinary and other procedures recommended for prophylaxis of bacterial endocarditis and procedures not recommended for prophylaxis are pointed out. General prophylactic regimens and specific antibiotics courses according to localization of potential source of bacteremia are postulated.

Keywords: Key words: bacterial endocarditis, severity of heart disease, risk of bacterial endocarditis, methods of prevention.

Published: June 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Heinc P. Instruction for prevention of bacterial endocarditis. Interní Med. 2006;8(6):270-273.
Download citation

References

  1. Beneš J, Kvasnička J. Infekční endokarditida. Cor Vasa 2000; 42 (2): K21-K28.
  2. Berney P, Francioli P. Successful prophylaxis of experimental streptococcal endocarditis with single-dose amoxicillin administered after bacterial challenge. J Infect Dis. 1990; 161: 281-285. Go to original source... Go to PubMed...
  3. Boudoulas H, Wooley CF. Mitral valve prolapse. In: Emmanouilides GC, Riemenschneider TA, Allen HD, et al. Heart Disease in Infants, Children, and Adolescents Including the Fetus and Young Adult. 5th ed. Baltimore, Md: Williams & Wilkins; 1995: 1063-1086.
  4. Cabell CHH, Abrutyn E, Karchmer AW. Bacterial endocarditis. The disease, treatment and prevention. Circulation 2003; 107: e185. Go to original source... Go to PubMed...
  5. Carabello BA. Mitral valve disease. Curr Probl Cardiol. 1993; 7: 423-478. Go to original source...
  6. Dajani AS, Bawdon RE, Berry MC. Oral amoxicillin as prophylaxis for endocarditis: what is the optimal dose? Clin Infect Dis. 1994; 18: 157-160. Go to original source... Go to PubMed...
  7. Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. Circulation. 1997; 96: 358-366. Go to original source... Go to PubMed...
  8. Devereux RB, Frary CJ, Kramer-Fox R, Roberts RB, Ruchlin HS. Cost-effectiveness of infective endocarditis prophylaxis for mitral valve prolapse with or without a mitral regurgitant murmur. Am J Cardiol. 1994; 74: 1024-1029. Go to original source... Go to PubMed...
  9. Devereux RB, Kramer-Fox R, Kligfield P. Mitral valve prolapse: causes, clinical manifestations and management. Ann Intern Med. 1989; 111: 305-317. Go to original source... Go to PubMed...
  10. Durack DT, Kaplan EL, Bisno AL. Apparent failures of endocarditis prophylaxis. JAMA 1983; 258: 2318-2322. Go to original source...
  11. Durack DT. Prevention of infective endocarditis. N Engl J Med. 1995; 332: 38-44. Go to original source... Go to PubMed...
  12. Gould IM, Buckingham JK. Cost effectiveness of prophylaxis in dental practise to prevent infective endocarditis. Br Heart J 1993; 70: 79-83. Go to original source... Go to PubMed...
  13. Imperiale TF, Horwitz GI. Does prophylaxis prevent postdental infective endocarditis? A controlled evaluation of protective efficacy. Am J Med 1990; 88: 131-136. Go to original source... Go to PubMed...
  14. Lacassin F, Hoen B, Leport C, et al. Procedures associated with infective endocarditis in adults. A case-control study. Eur Heart J 1995; 16: 1968-1974. Go to original source... Go to PubMed...
  15. Marks AR, Choong CY, Sanfilippo AJ, Ferre M, Weyman AE. Identification of high-risk and low-risk subgroups of patients with mitral-valve prolapse. N Engl J Med. 1989; 320: 1031-1036. Go to original source... Go to PubMed...
  16. McKinsey DS, Ratts TE, Bisno AL. Underlying cardiac lesions in adults with infective endocarditis. Am J Med. 1987; 82: 681-688. Go to original source... Go to PubMed...
  17. Nishimura RA, McGoon MD, Shub C, et al. Echocardiographically documented mitral-valve prolapse. N Engl J Med. 1985; 313: 1305-1309. Go to original source... Go to PubMed...
  18. Pallasch TJ, Slots J. Antibiotic prophylaxis and the medically compromised patient. Periodontol 2000. 1996; 10: 107-138. Go to original source... Go to PubMed...
  19. Saiman L, Prince A, Gersony WM. Pediatric infective endocarditis in the modern era. J Pediatr. 1993; 122: 847-853. Go to original source... Go to PubMed...
  20. Steckelberg JM, Wilson WR. Risk factors for infective endocarditis. Infect Dis Clin North Am. 1993; 7: 9-19. Go to original source... Go to PubMed...
  21. Sugrue D, Blake S, Troy P, MacDonald D. Antibiotic prophylaxis against infective endocarditis after normal delivery: is it necessary? Br Heart J. 1980; 44: 499-502. Go to original source... Go to PubMed...
  22. Van der Meer JT, Van Wijk W, Thompson J, et al. Efficasy of antibiotic prophylaxis for prevention of native-valve endocarditis. Lancet 1992; 339: 135-139. Go to original source... Go to PubMed...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.